Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Invest Dermatol ; 143(12): 2507-2514.e6, 2023 12.
Artigo em Inglês | MEDLINE | ID: mdl-37295490

RESUMO

Ozonated oil increases the healing of chronic diabetic wounds, but the underlying mechanisms remain unclear. We investigated the effect of topical ozonated oil on wound healing in mice with diabetes with diet-induced obesity and further elucidated the role of EGFR and IGF1R signaling in diabetic wound healing. We found that topical ozonated oil accelerated wound healing; increased phosphorylation of IGF1R, EGFR, and VEGFR; and improved vascularization at the wound leading edge in mice with diabetes with diet-induced obesity. Exposure of normal epidermal keratinocytes to ozonated medium (20 µM for 2 hours daily) increased cell proliferation and migration distance by increasing phosphorylation of IGF1R and EGFR and downstream phosphoinositide 3-kinase, protein kinase B, and extracellular signal-regulated kinase. These findings shed light on the mechanism for topical ozone action in chronic wounds and support its potential therapeutic application.


Assuntos
Diabetes Mellitus , Ozônio , Animais , Camundongos , Reepitelização , Fosfatidilinositol 3-Quinases , Cicatrização , Obesidade , Receptores ErbB
2.
Zhong Nan Da Xue Xue Bao Yi Xue Ban ; 32(6): 1020-5, 2007 Dec.
Artigo em Zh | MEDLINE | ID: mdl-18182720

RESUMO

OBJECTIVE: To investigate the expression of haptoglobin in the lesions of condyloma acuminatum (CA) at the mRNA and protein level, and to explore its role in the pathogenesis of CA. METHODS: The expressions of haptoglobin protein and mRNA in the skin tissues of 30 patients with CA and 20 normal controls were detected by immunohistochemistry(IHC), Western blot, and hybridization in situ. RESULTS: The in situ hybridization study showed that haptoglobin mRNA was expressed in the epidermal cells in the lesions of CA. The distribution of haptoglobin mRNA expression in the lesions of CA was similar to that of the normal controls, and the expression of haptoglobin mRNA in CA was higher than that of the normal controls. There was a significant difference in the positive expression of haptoglobin mRNA between the CA group and the control group (P<0.05). The immunohistochemical study showed that haptoglobin protein was expressed in the whole layers of epidermal keratinocytes in the lesions of CA at a high level and stronger staining was seen in the stratum basale and stratum spinosum. Haptoglobin protein was expressed predominantly in the stratum basale in normal skin tissues, while weak staining was seen below the stratum spinosum.There was a significant difference in the mean gray value between the CA group and control group (P<0.05). Western blot showed that the haptoglobin expression in CA lesions significantly increased compared with the normal skins (P<0.05). CONCLUSION: The expression of haptoglobin mRNA in the CA lesions obviously increases and the epidermal cells in the CA lesions are able to synthesize haptoglobin protein. Haptoglobin in the CA lesions may involve in the local immunity escape by preventing Langerhans cell functional maturation and inhibiting the immunocompetence of keratinocyte.


Assuntos
Condiloma Acuminado/metabolismo , Haptoglobinas/metabolismo , Adolescente , Adulto , Idoso , Western Blotting , Estudos de Casos e Controles , Condiloma Acuminado/genética , Células Epidérmicas , Haptoglobinas/genética , Humanos , Hibridização In Situ , Queratinócitos/metabolismo , Masculino , Pessoa de Meia-Idade , RNA Mensageiro/genética , Adulto Jovem
3.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 23(8): 596-8, 2003 Aug.
Artigo em Zh | MEDLINE | ID: mdl-14503059

RESUMO

OBJECTIVE: To observe the therapeutic effect of Xiaobai Mixture (XBM) in treating vitiligo. METHODS: Seventy-four patients with vitiligo were randomly divided into the XBM group treated with XBM and the control group treated with 8-MOP. The therapeutic effect, nail-fold microcirculation, plasma endothelin-1, serum immunoglobulin were observed and compared. RESULTS: The therapeutic effect of XBM was better than that of 8-MOP (P < 0.05). XBM could also obviously improve the nail-fold microcirculation, elevate the plasma endothelin-1 level and lower the serum IgG (P < 0.01). CONCLUSION: XBM has superiority in treating vitiligo.


Assuntos
Medicamentos de Ervas Chinesas/uso terapêutico , Fitoterapia , Vitiligo/tratamento farmacológico , Adolescente , Adulto , Endotelina-1/sangue , Feminino , Humanos , Imunoglobulina G/sangue , Masculino , Microcirculação , Pessoa de Meia-Idade , Unhas/irrigação sanguínea
4.
Nan Fang Yi Ke Da Xue Xue Bao ; 26(6): 831-2, 836, 2006 Jun.
Artigo em Zh | MEDLINE | ID: mdl-16793613

RESUMO

OBJECTIVE: To survey mycoplasma infection in female urogenital tract and analyze the drug sensitivity of mycoplasma in Changsha. METHODS: Ureaplasma urealyticum (Uu) and Mycoplasma hominis (Mh) were detected in 6566 cases of female urogenital tract infection by means of mycoplasma culture and drug sensitivity reagent kit. Sensitivity tests for 10 antibiotics were also performed. RESULTS: A total of 2938 cases were mycoplasma-positive (positivity rate of 44.75%), including 2469 Uu-positive cases (37.6%), 52 Mh-positive cases (0.08%) and 417 cases positive for both Uu and Mh (6.35%). Josamycin, doxycycline, clarithromycin and azithromycin were more effective against Uu infection. Josamycin, doxycycline and thiamphenicol were more effective against Mh infection. Mixed infection with Uu and Mh was more resistant to most antibiotics but Josamycin and doxycycline. CONCLUSION: The female urogenital mycoplasma infection results mainly from Uu. Compared with simple Uu or Mh infection, mixed infection with Uu and Mh has significantly greater resistance to a wider variety of drugs. Josamycin and doxycycline are the primary choice for female urogenital mycoplasma infection in Changsha.


Assuntos
Infecções por Mycoplasma/microbiologia , Mycoplasma hominis/efeitos dos fármacos , Infecções por Ureaplasma/microbiologia , Ureaplasma urealyticum/efeitos dos fármacos , Cervicite Uterina/microbiologia , Adolescente , Adulto , Idoso , China/epidemiologia , Doxiciclina/farmacologia , Doxiciclina/uso terapêutico , Farmacorresistência Bacteriana , Feminino , Humanos , Josamicina/farmacologia , Josamicina/uso terapêutico , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Infecções por Mycoplasma/tratamento farmacológico , Infecções por Mycoplasma/epidemiologia , Infecções por Ureaplasma/tratamento farmacológico , Infecções por Ureaplasma/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA